214 related articles for article (PubMed ID: 31609525)
1. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.
Orbai AM; Perin J; Gorlier C; Coates LC; Kiltz U; Leung YY; Palominos PE; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin S; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; Smolen JS; de Wit M; Gossec L
Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1772-1779. PubMed ID: 31609525
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
[TBL] [Abstract][Full Text] [Related]
3. Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis.
Queiro R; Cañete JD; Montilla C; Abad MA; Montoro M; Gómez S; Cábez A;
J Rheumatol; 2019 Jul; 46(7):710-715. PubMed ID: 30709957
[TBL] [Abstract][Full Text] [Related]
4. Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study.
Queiro R; Cañete JD; Montilla C; Abad M; Montoro M; Gómez S; Cábez A;
Arthritis Res Ther; 2017 Mar; 19(1):72. PubMed ID: 28356155
[TBL] [Abstract][Full Text] [Related]
5. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
6. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
[TBL] [Abstract][Full Text] [Related]
7. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.
Gorlier C; Orbai AM; Puyraimond-Zemmour D; Coates LC; Kiltz U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; de Wit M; Smolen JS; Gossec L
Ann Rheum Dis; 2019 Feb; 78(2):201-208. PubMed ID: 30442648
[TBL] [Abstract][Full Text] [Related]
8. Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.
Lucasson F; Kiltz U; Kalyoncu U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Ryussen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Richette P; Husni E; Coates LC; de Wit M; Smolen JS; Orbai AM; Gossec L
RMD Open; 2022 May; 8(1):. PubMed ID: 35523519
[TBL] [Abstract][Full Text] [Related]
9. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
10. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
[TBL] [Abstract][Full Text] [Related]
12. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study.
Leung YY; Eder L; Orbai AM; Coates LC; de Wit M; Smolen JS; Kiltz U; Palominos P; Canete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Soubrier M; Kalyoncu U; Gossec L
RMD Open; 2023 Sep; 9(3):. PubMed ID: 37709527
[TBL] [Abstract][Full Text] [Related]
13. Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis.
Leung YY; Orbai AM; de Wit M; Balanescu A; Dernis E; Soubrier M; Eder L; Smolen JS; Coates LC; Gossec L;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):593-602. PubMed ID: 31961492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Different Remission and Low Disease Definitions in Psoriatic Arthritis and Evaluation of Their Prognostic Value.
Coates LC; Gottlieb AB; Merola JF; Boone C; Szumski A; Chhabra A
J Rheumatol; 2019 Feb; 46(2):160-165. PubMed ID: 30323006
[TBL] [Abstract][Full Text] [Related]
15. A novel role for the psoriatic arthritis impact of disease (PsAID) questionnaire.
Johnson K; Ye JY; Chandran V; Gladman DD
Semin Arthritis Rheum; 2019 Oct; 49(2):241-245. PubMed ID: 31101369
[TBL] [Abstract][Full Text] [Related]
16. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
Haugeberg G; Michelsen B; Kavanaugh A
RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
[TBL] [Abstract][Full Text] [Related]
17. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
Lubrano E; Scriffignano S; Perrotta FM
J Rheumatol; 2020 Oct; 47(10):1490-1495. PubMed ID: 31676704
[TBL] [Abstract][Full Text] [Related]
18. Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.
Queiro R; Cañete JD; Montoro M; Gómez S; Cábez A;
Arthritis Res Ther; 2020 Apr; 22(1):82. PubMed ID: 32295620
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
Pontifex EK; Dissanayake K; Bursill D; Gill T
Int J Rheum Dis; 2019 Feb; 22(2):262-268. PubMed ID: 30450819
[TBL] [Abstract][Full Text] [Related]
20. Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab.
Coates LC; Rahman P; Psaradellis E; Rampakakis E; Osborne B; Lehman AJ; Nantel F
Rheumatology (Oxford); 2019 Mar; 58(3):522-526. PubMed ID: 30517715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]